← Back to Patent Explorer
US4816264A Expired / Lapsed US ⏱️ 0.0 years remaining

Sustained release formulations

Assignee: Warner Lambert Co LLC
•
Filing: 1986-06-06
•
Granted: 1989-03-28
•
Expires: 2006-06-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Drug delivery systems which exhibit sustained release properties when administered are produced using a "dual control" system which employs polymeric agents in core and membrane portions.

Inventors

  • 👤 Reginald Phillips
  • 👤 Krishnayya Bikkina
  • 👤 Sadath U. Khan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 22:25
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/20; A61K9/28; A61K9/2886; A61K9/2004; A61K9/2022; A61K9/205; A61K9/2054; A61K9/2806; A61K9/2833; A61K9/284; A61K9/2846; A61K9/286; A61K9/2866

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 93 words
In combination, a drug suitable for oral delivery and a delivery system for sustained release dosage of said drug comprising: (a) a core portion containing about 70 to 90% by weight of the drug and an effective amount of a cellulosic gelling polymer; and (b) a semipermeable membrane around said core containing effective amounts of a water soluble cellulosic polymer and a water insoluble acrylic polymer; said combination having 65 to 80% by weight drug and 20 to 30% by weight of the combination of gelling and membranal polymeric binders of the combination.
Claim 2
Dependent Claim 93 words
In combination, a drug suitable for oral delivery and a delivery system for sustained release dosage of said drug comprising: (a) a core portion containing about 70 to 90% by weight of the drug and an effective amount of a cellulosic gelling polymer; and (b) a semipermeable membrane around said core containing effective amounts of a water soluble cellulosic polymer and a water insoluble acrylic polymer; said combination having 65 to 80% by weight drug and 20 to 30% by weight of the combination of gelling and membranal polymeric binders of the combination.
Claim 3
Dependent Claim 12 words
The delivery system of claim 1 whenever the core contains hydroxyethyl cellulose.
Claim 4
Dependent Claim 12 words
The delivery system of claim 2 wherein the drug is procainamide hydrochloride.
Claim 5
Dependent Claim 67 words
A process for producing solid dosage forms which exhibit sustained release properties when administered which comprises the steps of: (1) producing a solid core containing effective amounts of at least one drug and at least one cellulosic gelling polymer, and (2) coating the core of step (1) with at least one semipermeable coating which contains effective amounts of water soluble cellulosic and water insoluble acrylic polymer components.
Claim 6
Dependent Claim 67 words
A process for producing solid dosage forms which exhibit sustained release properties when administered which comprises the steps of: (1) producing a solid core containing effective amounts of at least one drug and at least one cellulosic gelling polymer, and (2) coating the core of step (1) with at least one semipermeable coating which contains effective amounts of water soluble cellulosic and water insoluble acrylic polymer components.
Claim 7
Dependent Claim 13 words
The process of claim 4 wherein the gelling polymer comprises hydroxy ethyl cellulose.
Claim 8
Dependent Claim 37 words
The process of claim 4 wherein there is added the steps of: (3) coating the product of step (2) with a polymeric color coat, and (4) coating the product of step (3) with a polymeric clear coat.
Claim 9
Dependent Claim 12 words
The process of claim 6 wherein the gelling polymer comprises hydroxyethyl cellulose.

References Cited (Backward Citations)

GB1568837A Cited
US4008719A Cited
US4014334A Cited
US4252786A Cited
US4309996A Cited
US4320759A Cited
US4434153A Cited
US4389393A Cited
US4389393B1 Cited
US4519801A Cited
US4610870A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-03-27 1992-09-26 1993-03-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-03-27 1996-09-26 1997-03-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-03-27 2000-09-26 2001-03-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag